Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis
Authors
Keywords
NPM, Sold tumors, Prognosis, Meta-analysis
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-20
DOI
10.1186/s12885-018-4718-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Both high expression of nucleophosmin/B23 and CRM1 predicts poorer prognosis in human gastric cancer
- (2016) Fang Zhou et al. APMIS
- High expression of B23 is associated with tumorigenesis and poor prognosis in bladder urothelial carcinoma
- (2016) Haiping Wang et al. Molecular Medicine Reports
- Molecules that target nucleophosmin for cancer treatment: an update
- (2016) Adele Di Matteo et al. Oncotarget
- Nucleophosmin overexpression is associated with poor survival in astrocytoma
- (2015) Yen-Hsin Kuo et al. APMIS
- Upregulation of B23 promotes tumor cell proliferation and predicts poor prognosis in glioma
- (2015) Jianguo Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- NPM1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape
- (2015) Karl Holmberg Olausson et al. Scientific Reports
- Expression and Prognostic Significance of APE1/Ref-1 and NPM1 Proteins in High-Grade Ovarian Serous Cancer
- (2014) Ambrogio P. Londero et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Prognostic Role of Nucleophosmin in Colorectal Carcinomas
- (2014) Yu-Feng Yang et al. Asian Pacific Journal of Cancer Prevention
- Estrogen mediated expression of nucleophosmin 1 in human endometrial carcinoma clinical stages through estrogen receptor-α signaling
- (2014) Yunxiao Zhou et al. Cancer Cell International
- Regulatory role of nucleophosmin during the differentiation of human liver cancer cells
- (2014) DONG-HUI XU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Structural polymorphism in the N-terminal oligomerization domain of NPM1
- (2014) D. M. Mitrea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells
- (2012) Shao-Jung Lo et al. HEPATOLOGY
- Estrogen stimulates the proliferation of human endometrial cancer cells by stabilizing nucleophosmin/B23 (NPM/B23)
- (2012) Angel Chao et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Nucleophosmin expression in renal cell carcinoma and oncocytoma
- (2011) AYSEGUL SARI et al. APMIS
- Nucleophosmin is overexpressed in thyroid tumors
- (2010) Annalisa Pianta et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Nucleophosmin, p53, and Ki-67 expression patterns on an oral squamous cell carcinoma tissue microarray
- (2010) Cláudia Malheiros Coutinho-Camillo et al. HUMAN PATHOLOGY
- Nucleolar protein B23 has molecular chaperone activities
- (2010) Attila Szebeni et al. PROTEIN SCIENCE
- Nucleophosmin as a Candidate Prognostic Biomarker of Ewing's Sarcoma Revealed by Proteomics
- (2009) K. Kikuta et al. CLINICAL CANCER RESEARCH
- Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation
- (2008) Z. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started